These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL. Cancer Res; 1995 Jul 15; 55(14):3117-22. PubMed ID: 7606733 [Abstract] [Full Text] [Related]
6. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma. Nakashima T, Sun SY, Lotan R, Fujiwara T, Yasumatsu R, Komiyama S, Clayman GL. Laryngoscope; 2001 Aug 15; 111(8):1459-64. PubMed ID: 11568584 [Abstract] [Full Text] [Related]
7. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ. Cancer Res; 1995 Jan 01; 55(1):1-6. PubMed ID: 7805018 [Abstract] [Full Text] [Related]
8. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL. Cancer Res; 1994 Jul 15; 54(14):3662-7. PubMed ID: 8033080 [Abstract] [Full Text] [Related]
11. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA. Cancer Res; 1999 Jul 15; 59(14):3333-9. PubMed ID: 10416589 [Abstract] [Full Text] [Related]
14. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clayman GL, Frank DK, Bruso PA, Goepfert H. Clin Cancer Res; 1999 Jul 15; 5(7):1715-22. PubMed ID: 10430074 [Abstract] [Full Text] [Related]
15. [Effect of E1A gene on in vitro growth inhibition and radiochemosensitivity of lymph node metastasis cells of human head and neck squamous cell carcinoma]. Wang XL, Qian XL, Zhao QZ, Xu ZG, Tang PZ. Ai Zheng; 2003 Nov 15; 22(11):1140-6. PubMed ID: 14613640 [Abstract] [Full Text] [Related]
16. Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines. Higuchi Y, Asaumi J, Murakami J, Matsuzaki H, Wakasa T, Inoue T, Konoucni H, Hisatomi M, Yanagi Y, Honda Y, Shigehara H, Kishi K. Oncol Rep; 2003 Nov 15; 10(2):415-20. PubMed ID: 12579282 [Abstract] [Full Text] [Related]
17. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector. Dolivet G, Merlin JL, Barberi-Heyob M, Ramacci C, Erbacher P, Parache RM, Behr JP, Guillemin F. Cancer Gene Ther; 2002 Aug 15; 9(8):708-14. PubMed ID: 12136433 [Abstract] [Full Text] [Related]
18. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines. Liu TJ, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL. Cancer Gene Ther; 1999 Aug 15; 6(2):163-71. PubMed ID: 10195883 [Abstract] [Full Text] [Related]
19. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk. Morris JC, Wildner O. Mol Ther; 2000 Jan 15; 1(1):56-62. PubMed ID: 10933912 [Abstract] [Full Text] [Related]
20. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications. Horowitz J. Curr Opin Mol Ther; 1999 Aug 15; 1(4):500-9. PubMed ID: 11713766 [Abstract] [Full Text] [Related] Page: [Next] [New Search]